Help people with cancer
live longer and better.
About us
live longer and better.
Management Team
John Z. Gong, M.D., Ph.D
Chairman and CEO
— US FDA Reviewer for 10 years, conducted primary and critical reviews of numerous IND and NDA applications for both small molecules and biologics
— VP of Drug Development and Regulatory Affairs of BeiGene, CEO of BL Pharma, and CTO of JOINN Laboratories
— In the past 20+ years, he devoted into new drug R&D in different stakeholders from FDA, CRO to biotech companies. He gained rich experience by leading global new drug development, non-clinical and clinical trial designs, GLP, GCP regulations, molecule selection, developability assessment, and project risk management
— Committee member of the Chinese Pharmaceutical Association, Council member of AAALAC, member of editorial board of Chinese Journal of New Drugs, Progress in Pharmaceutical Sciences and DIA advisory committee
— Post-doc research in National Institutes of Health from 1996 to 1998, Ph.D. degree in Toxicology from New York University in 1996 and medical degree from Beijing Medical College in 1984
— Program Lead of China “Key Innovative Drug Development Program”
-
Dr. LIU Dongfang
Chief Medical Officer— Bachelor in Clinical medicine, Peking University School of Medicine; Master's degree, the University of Toledo; Ph.D. in Biological Engineering, MIT
— Worked for Celgene, Bristol Myers Squibb and Astrazeneca, 20+ years leadership experience in global clinical operations
-
ZHANG Jing / USCPA
Chief Finance Officer— Bachelor in Medicine, Sun Yat-sen University; Master in Accountancy, University of South Carolina
— Member of AICPA, worked for United Technologies and Anthem, 20+ years as global healthcare financial management executive in US MNC, health insurance company and big 4 audit firms
-
XIA Fang
Secretary to the Board, Registration— Master in Pharmacognosy, Peking University School of Medicine
— Worked as deputy director of product design center in Taiji Group in Beijing, responsible for product registration and regulatory communication, 15 years' experience in drug registration
-
Dr. LIN Yihui
Vice President, Translational Medicine Center— Ph.D. in Biology, Center for Excellence in Molecular Cell Science, CAS
— Worked for GlaxoSmithKline and the Institute of Health Sciences, experienced in biomarker validation and translational medicine
-
Dr. WEI Guoping
Vice President, Medicinal Chemistry— Ph.D. in Organic Chemistry, Chinese Academy of Sciences; Post-doc, The Ohio State University; Post-doc, University of California, Riverside
— Worked for Pharmaron, Wuxi AppTec, Acme Bioscience, and Berlex Biosciences, 20 years’ experience in drug discovery and development in medicinal chemistry
— Productive research results: 2 clinical candidate drugs 10 pre-clinical candidate drugs
-
Dr. LU Haolan
Executive Director, Data Analytics— Bachelor in Clinical Medicine, Peking University School of Medicine; Ph.D. & Master in Biostatistics, University of Minnesota
— Worked for Bristol Myers Squibb, was in charge of Nivolumab (OPDIVO®) NSCLC Project Analytics
-
XUE Zhiqiang
Executive Director, Clinical Operation— Bachelor in Pharmacy, Monash University
— Worked for Celgene, PRA Health Sciences, PPD and Quintiles, 20 years' experience in global clinical research
-
HE Yue
Senior Director, Quality Management— Master in Clinical Medicine, West China Hospital, Sichuan University
— Worked for BeiGene, Biotech Pharma and Tong-yang Pharmaceuticals, 17 years' clinical research experience
-
ZHU Ming
Vice President, Government Affair and Public Relation— Bachelor in Finance, Suzhou University
— Previous experience in WuXi AppTec, JOINN Laboratories and BL Pharma, 17 years operation management experience
-
Dr. DING Biao
Vice President, Human Resource— Ph.D. in Psychology, East China Normal University
— Previous experience in ciic Consulting, Luolai Home Textile and SAIC-GM, 18 years' experience in human resource management
-
Dr. LIU Dongfang
Chief Medical Officer— Bachelor in Clinical medicine, Peking University School of Medicine; Master’s degree, the University of Toledo; Ph.D. in Biological Engineering, MIT
— Worked for Celgene, Bristol Myers Squibb and Astrazeneca, 20+ years leadership experience in global clinical operations
-
ZHANG Jing / USCPA
Chief Finance Officer— Bachelor in Medicine, Sun Yat-sen University; Master in Accountancy, University of South Carolina
— Member of AICPA, worked for United Technologies and Anthem, 20+ years as global healthcare financial management executive in US MNC, health insurance company and big 4 audit firms
-
XIA Fang
Secretary to the Board, Registration— Master in Pharmacognosy, Peking University School of Medicine
— Worked as deputy director of product design center in Taiji Group in Beijing, responsible for product registration and regulatory communication, 15 years' experience in drug registration
-
Dr. LIN Yihui
Vice President, Translational Medicine Center— Ph.D. in Biology, Center for Excellence in Molecular Cell Science, CAS
— Worked for GlaxoSmithKline and the Institute of Health Sciences, experienced in biomarker validation and translational medicine
-
Dr. WEI Guoping
Vice President, Medicinal Chemistry— Ph.D. in Organic Chemistry, Chinese Academy of Sciences; Post-doc, The Ohio State University; Post-doc, University of California, Riverside
— Worked for Pharmaron, Wuxi AppTec, Acme Bioscience, and Berlex Biosciences, 20 years' experience in drug discovery and development in medicinal chemistry
— Productive research results: 2 clinical candidate drugs 10 pre-clinical candidate drugs
-
Dr. LU Haolan
Executive Director, Data Analytics— Bachelor in Clinical Medicine, Peking University School of Medicine; Ph.D. & Master in Biostatistics, University of Minnesota
— Worked for Bristol Myers Squibb, was in charge of Nivolumab (OPDIVO®) NSCLC Project Analytics
-
XUE Zhiqiang
Executive Director, Clinical Operation— Bachelor in Pharmacy, Monash University
— Worked for Celgene, PRA Health Sciences, PPD and Quintiles, 20 years' experience in global clinical research
-
HE Yue
Senior Director, Quality Management— Master in Clinical Medicine, West China Hospital, Sichuan University
— Worked for BeiGene, Biotech Pharma and Tong-yang Pharmaceuticals, 17 years' clinical research experience
-
ZHU Ming
Vice President, Government Affair and Public Relation— Bachelor in Finance, Suzhou University
— Previous experience in WuXi AppTec, JOINN Laboratories and BL Pharma, 17 years operation management experience
-
Dr. DING Biao
Vice President, Human ResourcePh.D. in Psychology, East China Normal University
Previous experience in ciic Consulting, Luolai Home Textile and SAIC-GM, 18 years’ experience in human resource management
